Cost control can be a great solution if your business is dealing with spiralling costs, cash flow problems and poor financial performance. It’s a process which can increase profits and improve ...
May 22 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 ...
* KEY ASPECTS OF THE COST CONTROL PROGRAM INCLUDE: ANNUALISED COST SAVINGS OF MORE THAN SEK 100 MILLION * KEY ASPECTS OF THE COST CONTROL PROGRAM INCLUDE: ABOUT 50% REDUCTION IN THE CASH BURN RATE TO ...
Global pharma giants AstraZeneca, Bristol Myers Squibb, Johnson & Johnson, Novartis, Pfizer and more are calling for the U.K. government to afford the industry more room for growth by revising a drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback